Irish trade surplus widens in September on pharma and US exports

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Ireland’s trade surplus widened in September as goods exports jumped by more than a quarter, driven by a sharp rise in pharmaceutical shipments and a doubling of exports to the US, according to Central Statistics Office data published on Wednesday.

The value of goods exports rose 28% to €28.5 billion in September up from €22.3 billion a year before.

Medical & pharmaceutical products accounted for almost two-thirds of all exports, increasing by €7.9 billion, or 74%, to €18.7 billion.

Exports to the US more than doubled, jumping 126% to €16.3 billion from €7.2 billion a year earlier. Chemical & related products made up more than 90% of this figure, totalling €14.8 billion.

Seasonally adjusted exports reached €27.4 billion, up 57% from August, marking an increase of €10.0 billion.

Imports also grew, but at a far slower pace, rising 3.7% to €11.1 billion. Seasonally adjusted imports fell 12% from August.

September’s trade surplus widened to €16.1 billion on a seasonally adjusted basis compared to €4.7 billion in August.

In the first nine months of 2025, total exports increased 28% to €212.2 billion, while imports rose 5.5% to €104.8 billion.

Exports to Great Britain - the UK excluding Northern Ireland - rose 22% to €1.4 billion, driven by food and chemical products. Imports from Great Britain increased 5.8% to €1.3 billion.

CSE statistician Jane Burmanje said pharmaceuticals drove the bulk of the overall growth, with the Medical & Pharmaceutical Products category representing 66% of total exports.

Copyright 2025 Alliance News Ltd. All Rights Reserved.